Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy

MV Sherrid, I Barac, WJ McKenna, PM Elliott… - Journal of the American …, 2005 - jacc.org
Objectives : In this study we assessed the long-term efficacy and safety of disopyramide for
patients with obstructive hypertrophic cardiomyopathy (HCM). Background : It has been …

Efficacy and safety of zonisamide: results of a multicenter study

IE Leppik, LJ Willmore, RW Homan, G Fromm… - Epilepsy Research, 1993 - Elsevier
… The safety and efficacy of zonisamide (ZNS), a new … 16-week open label, multicenter study.
The median percent reduction from … efficacy study followed by two sequential long-term safety

Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter …

E Abraham, R Wunderink, H Silverman, TM Perl… - Jama, 1995 - jamanetwork.com
Objective. —To evaluate the efficacy and safety of anti—tumor necrosis factor α monoclonal
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design. —…

Pediatric use of intravenous amiodarone: efficacy and safety in critically III patients from a multicenter protocol

JC Perry, AL Fenrich, JE Hulse, JK Trienman… - Journal of the American …, 1996 - Elsevier
OBJECTIVE.: The purpose of this study was to analyze the efficacy and safety of intravenous
amiodarone in young patients with critical, drug-resistant arrhythmias. BACKGROUND.: …

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double‐blind, placebo‐controlled trial

D van der Heijde, A Kivitz, MH Schiff… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To evaluate the safety and efficacy of adalimumab, a fully human recombinant IgG1
monoclonal antibody that specifically targets human tumor necrosis factor, in patients with …

A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia

H Lepor, S Auerbach, A Puras-Baez, P Narayan… - The Journal of …, 1992 - Elsevier
multicenter study was to determine the efficacy and safety of … , suggesting that further efficacy
may be achieved with doses of … demonstrates the safety and efficacy of terazosin for the …

[HTML][HTML] Laparoscopic nephrectomy for renal cell cancer: evaluation of efficacy and safety: a multicenter experience

JA Cadeddu, Y Ono, RV Clayman, PH Barrett… - Urology, 1998 - Elsevier
Objectives. Although laparoscopic radical nephrectomy is a safe and minimally invasive
alternative to open surgery, the long-term disease-free outcome of this procedure has not been …

[HTML][HTML] The efficacy and safety of the “hybrid” approach to coronary chronic total occlusions: insights from a contemporary multicenter US registry and comparison …

G Christopoulos, RV Menon… - The Journal of …, 2014 - ncbi.nlm.nih.gov
… The main finding of our multicenter registry are that the “hybrid” approach to CTO PCI is
associated with significantly higher success and similar complication rates compared to …

Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study

G Emmi, R Talarico, G Lopalco, R Cimaz, F Cantini… - Clinical …, 2016 - Springer
… The primary aims of the study were to evaluate the efficacy of ANA and CAN in a multicentric
cohort of BD. The secondary aims were to: (1) evaluate the overall safety profile of the …

Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety

E Stein - The American journal of cardiology, 1998 - Elsevier
… In conclusion, this pooled analysis of the efficacy and safety of cerivastatin has shown that
at doses of up to 0.4 mg/day, cerivastatin is an effective, safe, and well-tolerated agent for the …